RS
CRL icon

Ricky Sandler’s Charles River Laboratories CRL Stock Holding History

Ricky Sandler’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-435,454
Closed -$65.5M – 51
2025
Q1 		$65.5M Sell
435,454
-192,018
-31% -$32.2M 1.1% 37
2024
Q4 		$116M Sell
627,472
-376,000
-37% -$72.4M 1.77% 29
2024
Q3 		$198M Buy
+1,003,472
New +$209M 2.79% 11
2021
Q1 		– Sell
-67,994
Closed -$17M – 74
2020
Q4 		$17M Buy
+67,994
New +$16.2M 0.16% 73
2020
Q3 		– Sell
-126,539
Closed -$22.1M – 80
2020
Q2 		$22.1M Buy
+126,539
New +$20.2M 0.22% 69

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Ricky Sandler's CRL Position: Q2 2025 in Review

Ricky Sandler sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 435,454 shares — an estimated $65.5M sold.

Ricky Sandler first reported a position in CRL in Q2 2020 and held it in 5 quarters. The position peaked at $198M in Q3 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Ricky Sandler reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Ricky Sandler sold 435,454 Charles River Laboratories shares in Q2 2025, an estimated $65.5M.
  • Ricky Sandler first reported a position in Charles River Laboratories in Q2 2020 and held it in 5 quarters.
  • Ricky Sandler's Charles River Laboratories position peaked at $198M in Q3 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Eminence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.